Volume 17, Number 11—November 2011
Dispatch
Hepatitis E Virus in Rabbits, Virginia, USA
Article Contents
Abstract
We identified hepatitis E virus (HEV) in rabbits in Virginia, USA. HEV RNA was detected in 14 (16%) of 85 serum samples and 13 (15%) of 85 fecal samples. Antibodies against HEV were detected in 31 (36%) of 85 serum samples. Sequence analyses showed that HEV from rabbits is closely related to genotype 3.At least 4 major genotypes of HEV that infect mammals have been identified (5). Genotypes 1 and 2 are restricted to humans, and genotypes 3 and 4 have an expanded host range and are capable of causing zoonotic disease (6–10). Avian HEV from chickens likely represents a new genus within the family Hepeviridae (1,2). More recently, additional putative new genotypes of HEV were identified in rats in Germany (11) and wild boars in Japan (12). The objectives of this study were to determine if farmed rabbits in the United States are infected by HEV, and if so, to genetically identify these viruses from rabbits in the United States.
Fecal swab specimens and serum samples were obtained from 85 rabbits from 2 rabbit farms in Virginia, USA (25 rabbits from Farm A and 60 rabbits from Farm B). The 2 rabbit farms, 1 in eastern Virginia and 1 in southwestern Virginia, raised rabbits for meat consumption, fur, and pets. Ages of rabbits ranged from 3.9 to 36.8 months (mean 7.0 months) on Farm A and from 3.0 to 56.9 months (mean 10.8 months) on Farm B. Rabbits were of various breeds, including Californian, Flemish X, Lop, MiniRex, New Zealand, New Zealand X, Rex X, Salitan, and TN Redback. All rabbits appeared to be healthy.
Serum samples were tested for antibodies against HEV by using an ELISA essentially as described (13). A truncated recombinant genotype 1 HEV capsid protein containing the immunodominant 452–617 aa region (GenWay Biotech, Inc., San Diego, CA, USA) was used as antigen. Horseradish peroxidase–conjugated goat anti-rabbit IgG (Kirkegaard and Perry Laboratories, Gaithersburg, MD, USA) was used as the secondary antibody. Preinoculation serum and convalescent-phase serum obtained from 2 rabbits experimentally infected with rabbit HEV were included as negative and positive controls, respectively. The ELISA cutoff was calculated as the mean negative control optical density value plus 3 SD. The prevalence of IgG against HEV was 36.5% (31/85): 52% (13/25) for Farm A rabbits and 30% (18/60) for Farm B rabbits (Table 1).
All rabbit serum and fecal swab samples were tested for HEV RNA by using a nested reverse transcription PCR and a set of degenerate primers that amplify a conserved region of the HEV capsid gene. These primers were designed on the basis of multiple sequence alignment of the 2 known rabbit strains of HEV from China (3,4) and 75 other genotype 3 HEV strains. Primers used for the first-round PCR were forward primer RabdegF1 (5′-GCMACACGKTTYATGAARGA-3′) and reverse primer RabdegR1 (5′-ACYTTRGACCAATCVAGRGARC-3′). Primers used for the second-round PCR were forward primer RabdegF2 (5′-GCTGAYACRCTTCTYGGYG-3′) and reverse primer RabdegR2 (5′-TGAMGGRGTRGGCYGRTCYTG-3′).
HEV RNA was detected in 19 (22%) of 85 rabbits, including 14 (16%) of 85 serum samples and 13 (15%) of 85 fecal samples (Table 1). Authenticity of amplified PCR products was confirmed by sequencing. More rabbits were positive for HEV RNA on Farm A (48% and 40% in serum and fecal samples, respectively) than on Farm B (3% and 5% in serum and fecal samples, respectively) (Table 1). A total of 42 (49%) of 85 rabbits on the 2 farms were infected (fecal shedding, viremia, or seropositive): 20 (80%) of 25 on Farm A and 22 (37%) of 60 on Farm B (Table 1).
A 181-bp sequence within the capsid gene was identified in all 27 PCR-positive samples amplified. Sequence analyses identified 4 HEV isolates: USRab-14, USRab-16, USRab-31, and USRab-52. The 4 rabbit HEV isolates shared ≈81.2%–97.8% nt sequence identity with each other and 80.1%–95.6% nt sequence identity with the 2 rabbit HEV isolates from China (GDC9 and GDC46) (3). Small amounts of available clinical samples limited our ability to perform extensive genetic characterization of rabbit HEV isolates.
However, we amplified a larger 765-bp sequence within the capsid gene of isolate USRab-14 (Figure) by using a set of heminested primers: first-round PCR with primers RabdegF2 and RabOrf2R1 (reverse 5′-TTAAAACTCCCGGGTTTTACC-3′) and second-round PCR with primers RabOrf2F2 (forward 5′-CAGGTATTCTACTCCCGC-3′) and RabOrf2R1. Analysis of the 765-bp sequence (GenBank accession no. JN383986) showed that the USRab-14 isolate shared ≈87%–89% nt sequence identity with the 2 rabbit HEV strains from China (Table 2). Phylogenetic analysis showed that the USRab-14 isolate grouped with the 2 rabbit HEV strains from China (GDC9 and GDC46) (Figure), which are more closely related to genotype 3 HEV than to any other known HEV genotypes (Figure; Table 2). These results suggest that the rabbit HEV is likely a distant member of genotype 3 (14).
Serum samples were tested for antibodies against HEV by using an ELISA essentially as described (13). A truncated recombinant genotype 1 HEV capsid protein containing the immunodominant 452–617 aa region (GenWay Biotech, Inc., San Diego, CA, USA) was used as antigen. Horseradish peroxidase–conjugated goat anti-rabbit IgG (Kirkegaard and Perry Laboratories, Gaithersburg, MD, USA) was used as the secondary antibody. Preinoculation serum and convalescent-phase serum obtained from 2 rabbits experimentally infected with rabbit HEV were included as negative and positive controls, respectively. The ELISA cutoff was calculated as the mean negative control optical density value plus 3 SD. The prevalence of IgG against HEV was 36.5% (31/85): 52% (13/25) for Farm A rabbits and 30% (18/60) for Farm B rabbits (Table 1).
All rabbit serum and fecal swab samples were tested for HEV RNA by using a nested reverse transcription PCR and a set of degenerate primers that amplify a conserved region of the HEV capsid gene. These primers were designed on the basis of multiple sequence alignment of the 2 known rabbit strains of HEV from China (3,4) and 75 other genotype 3 HEV strains. Primers used for the first-round PCR were forward primer RabdegF1 (5′-GCMACACGKTTYATGAARGA-3′) and reverse primer RabdegR1 (5′-ACYTTRGACCAATCVAGRGARC-3′). Primers used for the second-round PCR were forward primer RabdegF2 (5′-GCTGAYACRCTTCTYGGYG-3′) and reverse primer RabdegR2 (5′-TGAMGGRGTRGGCYGRTCYTG-3′).
HEV RNA was detected in 19 (22%) of 85 rabbits, including 14 (16%) of 85 serum samples and 13 (15%) of 85 fecal samples (Table 1). Authenticity of amplified PCR products was confirmed by sequencing. More rabbits were positive for HEV RNA on Farm A (48% and 40% in serum and fecal samples, respectively) than on Farm B (3% and 5% in serum and fecal samples, respectively) (Table 1). A total of 42 (49%) of 85 rabbits on the 2 farms were infected (fecal shedding, viremia, or seropositive): 20 (80%) of 25 on Farm A and 22 (37%) of 60 on Farm B (Table 1).
A 181-bp sequence within the capsid gene was identified in all 27 PCR-positive samples amplified. Sequence analyses identified 4 HEV isolates: USRab-14, USRab-16, USRab-31, and USRab-52. The 4 rabbit HEV isolates shared ≈81.2%–97.8% nt sequence identity with each other and 80.1%–95.6% nt sequence identity with the 2 rabbit HEV isolates from China (GDC9 and GDC46) (3). Small amounts of available clinical samples limited our ability to perform extensive genetic characterization of rabbit HEV isolates.
However, we amplified a larger 765-bp sequence within the capsid gene of isolate USRab-14 (Figure) by using a set of heminested primers: first-round PCR with primers RabdegF2 and RabOrf2R1 (reverse 5′-TTAAAACTCCCGGGTTTTACC-3′) and second-round PCR with primers RabOrf2F2 (forward 5′-CAGGTATTCTACTCCCGC-3′) and RabOrf2R1. Analysis of the 765-bp sequence (GenBank accession no. JN383986) showed that the USRab-14 isolate shared ≈87%–89% nt sequence identity with the 2 rabbit HEV strains from China (Table 2). Phylogenetic analysis showed that the USRab-14 isolate grouped with the 2 rabbit HEV strains from China (GDC9 and GDC46) (Figure), which are more closely related to genotype 3 HEV than to any other known HEV genotypes (Figure; Table 2). These results suggest that the rabbit HEV is likely a distant member of genotype 3 (14).
We report that farmed rabbits in the United States are naturally infected with antibodies against HEV and that HEV RNA was detected in various breeds of rabbits from 2 farms in Virginia, USA. The prevalence of antibodies against HEV and HEV RNA was higher on Farm A than on Farm B. This variation may reflect differences in rabbit housing practices on the 2 farms: rabbits on Farm A were caged in groups of 2–9 and rabbits on Farm B were each caged individually. Because HEV is transmitted by the fecal–oral route, virus likely spreads between cage mates on Farm A, thus increasing the numbers of HEV-positive rabbits.
The overall prevalence of antibodies against HEV (36%) among rabbits from the United States was lower than that among rabbits from Gansu and Beijing, China (57% and 55%, respectively) (3,4). The prevalence of HEV RNA in serum and fecal samples on rabbit farms in the United States (16.5% and 15.3%, respectively) was higher than that on farms in Gansu and Beijing, China (7.5% and 6.96%, respectively). Ages of rabbits, animal housing practices, and hygienic conditions on rabbit farms may explain the observed difference in HEV prevalence.
Sequence analysis of the 765-bp capsid gene showed that HEV isolate USRab-14 from the United States is genetically different from the 2 rabbit strains of HEV from China (Table 2; Figure). Genetic variations were also observed among the 4 rabbit HEV isolates from the 2 rabbit farms in the United States. Rabbit HEV strains from the United States and China clustered into a distinct branch closely related to genotype 3 HEV.
Thus, similar to swine HEV in pigs (13) and avian HEV in chickens (15), rabbit HEV is also widespread in the rabbit population in the United States. The fact that rabbit HEV appears to be closely related to genotype 3 HEV raises a potential concern for zoonotic infection because genotype 3 HEV from other animal species is known to infect humans (1,2). Therefore, cross-species infection and zoonotic risk for infection with rabbit HEV should be evaluated.
The overall prevalence of antibodies against HEV (36%) among rabbits from the United States was lower than that among rabbits from Gansu and Beijing, China (57% and 55%, respectively) (3,4). The prevalence of HEV RNA in serum and fecal samples on rabbit farms in the United States (16.5% and 15.3%, respectively) was higher than that on farms in Gansu and Beijing, China (7.5% and 6.96%, respectively). Ages of rabbits, animal housing practices, and hygienic conditions on rabbit farms may explain the observed difference in HEV prevalence.
Sequence analysis of the 765-bp capsid gene showed that HEV isolate USRab-14 from the United States is genetically different from the 2 rabbit strains of HEV from China (Table 2; Figure). Genetic variations were also observed among the 4 rabbit HEV isolates from the 2 rabbit farms in the United States. Rabbit HEV strains from the United States and China clustered into a distinct branch closely related to genotype 3 HEV.
Thus, similar to swine HEV in pigs (13) and avian HEV in chickens (15), rabbit HEV is also widespread in the rabbit population in the United States. The fact that rabbit HEV appears to be closely related to genotype 3 HEV raises a potential concern for zoonotic infection because genotype 3 HEV from other animal species is known to infect humans (1,2). Therefore, cross-species infection and zoonotic risk for infection with rabbit HEV should be evaluated.
Ms Cossaboom is a student in the DVM/PhD dual-degree program at Virginia Polytechnic Institute and State University. Her research interests include emerging and zoonotic viral diseases of public health significance.
Acknowledgments
We thank the rabbit farmers for allowing us to collect rabbit samples, Lynn Chipkin for helping with sample collection, and Nathan Beach for assisting with phylogenetic analysis.
This study was supported in part by grants (R01AI050611 and R01AI074667) from the US National Institutes of Health.
This study was supported in part by grants (R01AI050611 and R01AI074667) from the US National Institutes of Health.
References
- Meng XJ. Recent advances in hepatitis E virus. J Viral Hepat. 2010;17:153–61. DOIPubMed
- Meng XJ. Hepatitis E virus: animal reservoirs and zoonotic risk. Vet Microbiol. 2010;140:256–65. DOIPubMed
- Zhao C, Ma Z, Harrison TJ, Feng R, Zhang C, Qiao Z, A novel genotype of hepatitis E virus prevalent among farmed rabbits in China. J Med Virol. 2009;81:1371–9. DOIPubMed
- Geng J, Wang L, Wang X, Fu H, Bu Q, Zhu Y, Study on prevalence and genotype of hepatitis E virus isolated from Rex rabbits in Beijing, China. J Viral Hepat. 2011;18:661–7. DOIPubMed
- Ahmad I, Holla RP, Jameel S. Molecular virology of hepatitis E virus. Virus Res. 2011;161:47–58. DOIPubMed
- Arankalle VA, Chobe LP, Chadha MS. Type-IV Indian swine HEV infects rhesus monkeys. J Viral Hepat. 2006;13:742–5. DOIPubMed
- Purcell RH, Emerson SU. Hepatitis E: an emerging awareness of an old disease. J Hepatol. 2008;48:494–503. DOIPubMed
- Teo CG. Much meat, much malady: changing perceptions of the epidemiology of hepatitis E. Clin Microbiol Infect. 2010;16:24–32. DOIPubMed
- Aggarwal R, Krawczynski K. Hepatitis E: an overview and recent advances in clinical and laboratory research. J Gastroenterol Hepatol. 2000;15:9–20. DOIPubMed
- Okamoto H. Genetic variability and evolution of hepatitis E virus. Virus Res. 2007;127:216–28. DOIPubMed
- Johne R, Plenge-Bönig A, Hess M, Ulrich RG, Reetz J, Schielke A. Detection of a novel hepatitis E-like virus in faeces of wild rats using a nested broad-spectrum RT-PCR. J Gen Virol. 2010;91:750–8. DOIPubMed
- Takahashi M, Nishizawa T, Sato H, Sato Y, Jirintai D, Nagashima S, Analysis of the full-length genome of a hepatitis E virus isolate obtained from a wild boar in Japan that is classifiable into a novel genotype. J Gen Virol. 2011;92:902–8. DOIPubMed
- Meng XJ, Purcell RH, Halbur PG, Lehman JR, Webb DM, Tsareva TS, A novel virus in swine is closely related to the human hepatitis E virus. Proc Natl Acad Sci U S A. 1997;94:9860–5. DOIPubMed
- Purdy MA, Khudyakov YE. Evolutionary history and population dynamics of hepatitis E virus. PLoS ONE. 2010;5:e14376. DOIPubMed
- Huang FF, Haqshenas G, Shivaprasad HL, Guenette DK, Woolcock PR, Larsen CT, Heterogeneity and seroprevalence of a newly identified avian hepatitis E virus from chickens in the United States. J Clin Microbiol. 2002;40:4197–202. DOIPubMed
Figure
Tables
Suggested citation for this article: Cossaboom CM, Córdoba L, Dryman BA, Meng X-J. Hepatitis E virus in rabbits, Virginia, USA. Emerg Infect Dis [serial on the Internet]. 2011 Nov [date cited]. http://dx.doi.org/10.3201/eid1711.110428
No hay comentarios:
Publicar un comentario